申请人:Merck Patent Gesellschaft mit Beschrankt Patents
公开号:US20010021709A1
公开(公告)日:2001-09-13
Compounds of the formula I
1
in which
X, Y, Z, R
1
, R
2
, R
3
, R
4
, R
5
, R
7
, R
8
, R
11
, m and n have the meanings stated in claim
1,
and their physiologically acceptable salts can be used as integrin inhibitors, in particular for the prophylaxis and treatment of circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, for pathological processes maintained or propagated by angiogenesis, and in tumour therapy.
公式I1的化合物,其中X、Y、Z、R1、R2、R3、R4、R5、R7、R8、R11、m和n具有权利要求1中所述的含义,并且它们的生理上可接受的盐可用作整合素
抑制剂,特别用于预防和治疗循环障碍、血栓形成、心肌梗死、冠心病、动脉硬化、骨质疏松症、由血管生成维持或传播的病理过程以及肿瘤治疗。